RedHill Biopharma (RDHL) Shares Outstanding (Diluted) (2011 - 2025)
RedHill Biopharma (RDHL) Shares Outstanding (Diluted) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 833.33 Mn |
| 10 | RedHill Biopharma | 1.99 Bn | 1.99 Bn | - | 1.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.03 Bn |
| Jun 30, 2025 | 18.03 Bn |
| Dec 31, 2024 | 11.76 Bn |
| Jun 30, 2024 | 11.76 Bn |
| Dec 31, 2023 | 51.12 Mn |
| Jun 30, 2023 | 51.12 Mn |
| Mar 31, 2023 | 21.86 Mn |
| Dec 31, 2022 | 21.86 Mn |
| Sep 30, 2022 | 21.86 Mn |
| Jun 30, 2022 | 21.86 Mn |
| Mar 31, 2021 | 231,204.00 |
| Dec 31, 2020 | 231,204.00 |
| Sep 30, 2020 | 231,204.00 |
| Jun 30, 2020 | 231,204.00 |
| Mar 31, 2020 | 231,204.00 |
| Dec 31, 2019 | 231,204.00 |
| Sep 30, 2019 | 231,204.00 |
| Jun 30, 2019 | 231,204.00 |
| Mar 31, 2019 | 231,204.00 |
| Dec 31, 2018 | 231,204.00 |